Hamad and Shams join Baptist Medical Associates Prospect
PROSPECT Mitra Shams, MD, and Reem Hamad, MD, have joined Baptist Medical Associates Prospect.
Shams is a 1994 graduate of the University of Vienna Medical School in Vienna, Austria. She completed her family medicine residency at Southern Illinois University School of Medicine in Springfield in 1999 and her internal medicine residency at St. John’s Mercy Medical Center in St. Louis in 2002. Shams is board certified in internal medicine.
Hamad is a 1987 graduate of the Damascus University Faculty of Medicine. She completed her internal medicine residency at University of Louisville Hospital in 1995. Hamad is board certified in internal medicine.
Byrum, Hoffman, and Mandzy join Baptist Medical Associates
LOUISVILLE Henry Byrum, MD, Russell Hoffman, MD, and Lana Mandzy, MD, internal medicine, have joined Baptist Medical Associates. Their practice is located at 4003 Kresge Way, Ste. 400.
Byrum is a 1974 graduate of the University of Vermont College of Medicine in Burlington. He completed his internship and residency at the University of Kentucky in 1977. He is board certified in internal medicine.
Mandzy is a 1986 graduate of the Kyiv Medical Institute in Ukraine. She received a PhD from the Scientific Research Institute of Occupational Health and Work-Related Diseases in Kyiv in 1992. She completed her internal medicine internship and residency at University of Louisville Hospital in 1999 and 2001, respectively. Mandzy is board certified in general surgery. She is fluent in English, Ukranian, and Russian and knows some Polish and Slovak.
Hoffman is a 1976 graduate of the University of Louisville School of Medicine. He completed his internal medicine internship and residency at Indiana University in 1979. He completed a fellowship in endocrinology and diabetes at Indiana University in 1980. He is board certified in internal medicine.
Shee, Sutkamp, Swift, and Kim join Baptist Medical Associates
LOUISVILLE Jun Oh Kim, MD, George Shee, MD, Michael Sutkamp, MD, and James Swift, MD, FACP, internal medicine, have joined Baptist Medical Associates. Their practice is located at 4002 Kresge Way, Ste. 124.
Kim is a 1998 graduate of the University of Louisville School of Medicine. He completed his internal medicine internship and residency at Good Samaritan Regional Medical Center and Carl T. Hayden VA Medical Center in Phoenix, Arizona, in 2001. He is board certified in internal medicine and is fluent in conversational Korean.
Shee is a 1973 graduate of the University of Louisville School of Medicine. He completed his internal medicine internship and residency at St. Joseph Infirmary in Louisville in 1976.
Sutkamp is a 1990 graduate of the University of Louisville School of Medicine. He completed his internal medicine internship and residency at Christ Hospital in Cincinnati, Ohio, in 1993. Sutkamp is board certified in internal medicine.
Swift is a 1980 graduate of the State University of New York College of Medicine in Syracuse. He completed his internal medicine internship and residency at Letterman Army Medical Center in San Francisco, California, in 1983. Swift is board certified in internal medicine.
Shelbyville practice becomes Baptist OB/GYN Associates
SHELBYVILLE Arlene Kraut, MD, has joined Baptist OB/GYN Associates, part of Baptist Medical Associates. Kraut is a 1996 graduate of the Mount Sinai School of Medicine in New York, New York. She completed her obstetrics and gynecology residency at Maimonides Medical Center in Brooklyn, New York. Kraut is board certified in obstetrics and gynecology.
CBH Hosts Open House at New Beaumont Facility
LEXINGTON Central Baptist Hospital is hosting an open house at its new Beaumont facility at 3084 Lakecrest Circle on February 5. Visitors can tour the facility as well as enjoy light refreshments during the open house event from 4–7 p.m.
The new facility is home to Baptist Internal Medicine & Endocrinology at Beaumont, where female internal medicine physicians Christine Ko, MD; Vinette Little, MD; Carol Mitchell, MD; Chitra Raghavan, MD, and Shannon Roberts, DO, provide a full spectrum of adult primary care to both men and women. Providers Sarah Grimm, PA-C, and Angela Lanter, APRN, can accommodate same-day visits for patient convenience.
Also in the practice are endocrinologists Kristina Humphries, MD, and Anna Marino, MD., who each have specific interests in care for diabetes and thyroid disorders.
Central Baptist Hospital Breast Imaging Services is also in the new facility, providing state-of-the-art digital screening mammography and bone densitometry. It is one of six CBH Breast Imaging Services locations serving the region under the guidance of breast radiologists Sandra Bates, MD; Molly Hester, MD; Francie Masters, MD; Angela Moore, MD, and Medical Director Tamara Patsey, MD.
Baptist Health Names Hanson as President & CEO
LOUISVILLE Baptist Health (formerly Baptist Healthcare System) has named Stephen C. Hanson president and chief executive officer, effective March 8. Hanson succeeds President and Chief Executive Officer Tommy J. Smith, who announced his retirement last year.
Hanson, 61, has served in various senior leadership positions for Texas Health Resources since 2005, most recently as executive vice president and operations leader for the region covering Dallas-Fort Worth. Texas Health Resources is one of the largest faith-based, nonprofit health systems in the United States and includes 25 affiliated acute care and short-stay hospitals.
Hanson also served as president and CEO of Kentucky-based Appalachian Regional Healthcare from 1999 to 2005, so this represents a return to Kentucky for him and his family.
Davenport named COO/CNO for Ephraim McDowell Health
DANVILLE Sally Davenport, RN, MS, NEA-BC, has been named Ephraim McDowell Health’s Chief Operating Officer/Chief Nursing Officer with responsibility for nursing and clinical operations for Ephraim McDowell Regional Medical Center, Ephraim McDowell Fort Logan Hospital, Ephraim McDowell Clinics, A Children’s Place, and McDowell Place of Danville.
Davenport joined Ephraim McDowell Regional Medical Center in 2007 and most recently served as vice president of patient care services/chief nursing officer. She is a seasoned nurse executive with 25 years of experience in nursing administration as well as a clinical foundation in oncology nursing and hospital staff development. Davenport received her baccalaureate degree from the University of Nebraska at Kearney, Nebraska, and her master’s degree from Creighton University in Omaha, Nebraska, and completed the Johnson and Johnson Wharton School of Business Executive Nurse Fellowship. She also earned Nursing Executive, Advanced (NEA-BC) certification from the American Nurses Credentialing Center.
Norton Cancer Institute Qualified by NCCN ARP
LOUISVILLE The National Comprehensive Cancer Network® (NCCN®) Affiliate Research Project (ARP), developed by the NCCN Oncology Research Project (ORP), has qualified Norton Cancer Institute, a community-based affiliate of Moffitt Cancer Center—one of the 21 NCCN Member Institutions.
Located in Louisville, Kentucky, Norton Cancer Institute is operating as an ARP site under the leadership of John Hamm, MD, Medical Director, Norton Cancer Institute Research Program.
Norton Cancer Institute is the eighth community-based NCCN Member Institution affiliate to qualify for the NCCN ARP, increasing the scope of potential patients for the more than 60 actively accruing ORP trials.
Norton Cancer Institute will have access to new and innovative cancer drugs for patients in collaboration with NCCN Member Institutions; Principal Investigators of NCCN-funded studies will have access to Norton Cancer Institute as an NCCN-qualified community site.
Norton Neuroscience Institute first in Louisville to offer new treatment for recurrent glioblastoma brain tumors
LOUISVILLE Norton Neuroscience Institute is the only clinical provider in Louisville to offer a new treatment for recurrent glioblastoma brain tumors using the NovoTTF-100A system. This noninvasive device produces alternating electrical fields that target tumor sites and disrupt the rapid cell division exhibited by cancer cells. As glioblastomas remain the most common and destructive primary brain tumors, the innovative NovoTTF-100A technology at Norton Neuroscience Institute will provide patients in Kentucky and Indiana with an alternative therapy after surgical and radiation options have been exhausted.
Glioblastomas are tumors that arise from astrocytes, the cells that make up the supportive tissue of the brain. These tumors are highly malignant because the cells reproduce quickly and are supported by a large network of blood vessels. Glioblastomas represent 17 percent of all primary brain tumors, according to the American Brain Tumor Association. Although they are the most common type of primary brain tumors, treatment remains difficult because the tumors contain varying types of cells. The NovoTTF-100A technology offers new hope for patients with recurrent glioblastomas.
The NovoTTF-100A system was approved by the U.S. Food and Drug Administration in April 2011 and Norton Healthcare acquired the device in August 2012. Certified physicians such as Renato V. LaRocca, MD, cancer medicine specialist and neuro oncologist with the Brain Tumor Center, a collaboration of Norton Neuroscience Institute and Norton Cancer Institute and David A. Sun, MD, PhD, neurosurgeon with Norton Neuroscience Institute, are currently using this technology on brain tumor patients in Louisville and hope to extend treatment to glioblastoma patients throughout the region.
Baptist Medical Associates receives recognition for diabetes care
LOUISVILLE AND LAGRANGE Nineteen Baptist Medical Associates physicians, physician assistants, and nurse practitioners have received recognition from the Diabetes Recognition Program of the National Committee for Quality Assurance (NCQA) and the American Diabetes Association (ADA) for providing quality care to their patients with diabetes.
The physicians, physician assistants, and nurse practitioners, located in Louisville and La Grange, recognized are: Michael Davis, MD; Charles Gaba, MD; Albert Hoskins, MD; Keith Krawiec, MD; Douglas Marquess, MD; Sarah Merrick, MD; Tami Secor, MD; Brenda Townes, MD; Stacey Waring, MD; and Jill Watson, MD; all internal medicine; Tonya Perkins, MD, internal medicine and pediatrics; Donna Gatewood, MD; Ray Johnson, MD; Gerlinda Lowrey, MD; and Jeffrey Reynolds, MD; all family medicine; Physician Assistant Amy Davis, PA-C; and Nurse Practitioners Terri Clifford, APRN; Abby Hefner, APRN; and Cheryl Thurman.
Jewish Hospital Implants Temporary Neurostimulator
LOUISVILLE The first temporary endoscopic neurostimulator implantation in the region was performed recently at Jewish Hospital, part of KentuckyOne Health. For patients with severe gastroparesis, a disorder that slows or stops the movement of food from the stomach to the small intestine, this procedure can determine if a permanent implant will restore their ability to digest.
The temporary implant was followed by placement of a permanent device, which stimulates the nerves and muscles in the stomach to aid digestion in a manner similar to how a pacemaker is used to control heart rhythm.
The temporary endoscopic procedure was performed by Thomas Abell, MD, director of the Jewish Hospital GI Motility Clinic and the Arthur M. Schoen, MD, chair in Gastroenterology at the University of Louisville, who specializes in gastric motility, the movements of the stomach that aid in digestion by moving food into the small intestine. The permanent device was placed by Robert Cacchione, MD, associate professor of Surgery at UofL. Cacchione has extensive experience with gastric stimulation devices.
Abell pioneered the development of the implantable neurostimulator with medical device manufacturer Medtronic while at the University of Tennessee. His research includes conducting National Institutes of Health-sponsored clinical trials to standardize the treatment protocols for gastroparesis while at the University of Mississippi. One such trial is now under way at the University of Louisville.
Jewish Orthopaedic Care Develops New Protocol
LOUISVILLE Orthopaedic surgeons and anesthesiologists with Jewish Orthopaedic Care, a part of KentuckyOne Health, have researched and implemented a new protocol that has drastically reduced the number of patients who require a blood transfusion following total joint replacement surgery. The program has significant benefits to patients.
Jewish Orthopaedic Care teams are using transexamic acid, a medication that works to reduce blood loss, for patients undergoing total knee and hip replacement surgeries. Their research showed the use of the medication protocol reduced the number of patients who required a blood transfusion dropped from 14 percent to 2 percent in total knee replacement surgeries. The study will be submitted for consideration to The Journal of Arthroplasty.
“Our research has led us to introduce this treatment protocol to other orthopeadic surgeons in our healthcare system,” said Arthur Malkani, M.D., orthopaedic surgeon, Shea Orthopaedic Group, Jewish Physician Group. “In addition to the overall health benefits to our patient, this protocol benefits our entire system. By reducing the number of transfusions needed, we can preserve blood supply and save valuable health care resources for other patients.”
“The mortality rate is higher for patients who require a blood transfusion and those patients don’t do as well,” said Jiapeng Huang M.D., Medical Director of Anesthesia, Jewish Hospital Medical Campus. “Eliminating the need for a blood transfusion is safer for the patient and reduces overall medical costs affiliated with the procedure.”
Central Baptist Hospital’s Orthopedic Program Earns Certification from The Joint Commission
LEXINGTON Central Baptist Hospital has earned The Joint Commission’s Gold Seal of Approval® for its Orthopedic Program, specifically Hip and Knee, by demonstrating compliance with national standards for health care quality and safety in disease-specific care.
As of November 15, 2012, Central Baptist was the only hospital in Lexington and one of only four programs in Kentucky to hold this certification.
CBH First in Kentucky to Receive SCPC A-Fib Certification
LEXINGTON Central Baptist Hospital has received full Atrial Fibrillation Certification status from the Society of Cardiovascular Patient Care (SCPC). CBH is the first healthcare facility in Kentucky to receive this certification and is one of only 12 programs in the country to earn the honor.
Central Baptist Hospital has demonstrated its expertise and commitment to quality patient care by meeting or exceeding a wide set of stringent criteria and undergoing a comprehensive review by an accreditation review specialist from the SCPC. Central Baptist’s protocol-driven and systematic approach to patient evaluation and management allows physicians to reduce time to treatment and to help patients to decrease their length of stay in the emergency department and the hospital.
Norton moves practices from Dorsey Plaza to Middletown
LOUISVILLE On January 11, 2013, Norton Immediate Care Center – Dorsey Plaza and Norton Community Medical Associates – Dorsey moved to a new, state-of-the-art facility and were renamed Norton Immediate Care Center – Middletown and Norton Community Medical Associates – Middletown. The new space, located at 12903 Shelbyville Road, will provide a patient-focused environment for area families and bring the newest in health care technology to the Middletown area.
The previous site for the immediate care center and physician practice was at 10284 Shelbyville Road in Dorsey Plaza. With much of the area’s patient population moving toward Middletown, that location was no longer the most convenient.
While convenience is a key factor for the move, the growth potential for the new location is also a large benefit to patients and employees. All patient exam rooms have been equipped with the Epic electronic medical records system to ensure the most effective and efficient care possible as well as allow patients to access their own medical records. The new facility will also have updated furnishings, additional parking, more spacious rooms and be handicap accessible.
Ambati Receives International Ophthalmology Award
LEXINGTON Dr. Jayakrishna Ambati, professor and vice chair in the Department of Ophthalmology and Visual Sciences and professor of Physiology at the University of Kentucky College of Medicine, was awarded the 2013 Prix Soubrane de la Recherche en Ophtalmologie for his contributions to research in age-related macular degeneration (AMD).
The award was presented on Jan. 11 at the 7th Annual Macula of Paris Congress in Paris, France, by Dr. Gisèle Soubrane, professor of ophthalmology and chair emeritus at the University of Paris East-Creteil, for whom the award is named. This annual conference brings the most highly regarded clinicians and researchers from around the world together to discuss treatments of the future for macular diseases.
Ambati is the first physician to receive this award since it was instituted in 2011 to recognize and distinguish a physician/ scientist for his or her work in basic and clinical research.
The Ambati team at UK has made pioneering contributions in AMD and ocular angiogenesis and elucidated the mechanisms of inflammation, innate immunity, and RNA biology in the pathogenesis of AMD. His laboratory reported numerous seminal advances in journals such as Nature, Cell, Nature Medicine, New England Journal of Medicine, PNAS and JCI.
Ambati, the Dr. E. Vernon & Eloise C. Smith Endowed Chair in Macular Degeneration at UK, accepted his award on behalf of his research group.
Jewish Hospital Launches “STEMI Network”
LOUISVILLE A new program at Jewish Hospital – called the STEMI Network – will reduce the time between heart attack and care. Patients presenting with symptoms of acute myocardial infarction will be handed off directly to a special team that will bypass the ER and take the patient straight to the cardiac catheterization lab. For patients with a heart attack or a complete blockage of the coronary artery, it will ensure the fastest access to life saving care in Louisville Metro.
STEMI is an acronym meaning “ST segment elevation myocardial infarction,” which is a type of heart attack. This is determined by an electrocardiogram (EKG) test. A STEMI is a more severe type of heart attack.
Through the STEMI Network, which launched December 1, the Emergency Department at Jewish Hospital receives EKG results transmitted wirelessly by Louisville Metro EMS (LMEMS) providers when they suspect that the patient is having a STEMI in the field. Once the emergency department receives the patient’s EKG, they will confirm whether the heart attack is one with elevated ST segments—a pattern on an EKG reading that indicates a total blockage. If a total blockage is suspected, the emergency physician will then activate the cath lab team. When LMEMS arrives at the hospital, hospital staff will transport the patient directly to the cath lab, allowing physicians to clear the blockage sooner.
“For patients with a complete blockage, urgent treatment can decrease the extent of heart muscle damage and thereby improve mortality risk,” said Steven Raible, M.D. “Our goal is to limit the damage to the heart and improve outcomes by getting patients in the cath lab as quickly as possible.”
While all heart attacks are serious, those considered a STEMI, which involves a total artery blockage, are those requiring the quickest treatment. Because of the total blockage, STEMI heart attacks cause rapid loss of heart muscle that cannot be regenerated. In these situations, time saved is muscle saved.
Third hyperbaric chamber added at Baptist Hospital East
ST MATTHEWS A third hyperbaric chamber has been added at Baptist Hospital East to help handle the increasing demand for treatment of slow-healing wounds.
The new unit was delivered and installed on Friday, Dec. 7 in the Wound Care Center, located on the first floor of the Baptist East Medical Pavilion, 3900 Kresge Way, on the hospital’s campus.
Patients with diabetic ulcers and other types of slow-healing wounds can benefit from hyperbaric oxygen therapy (HBOT) used to treat wounds that have shown no improvement in four weeks of conventional treatment. Pressure ulcers, traumatic wounds, problem surgical wounds and other types of complex soft-tissue injuries may also be treated at the center.
Paily voted Best of Kentuckiana
Rejith Paily, MD, FACP, an Internal Medicine/Primary Care physician with Jewish Physician Group, a part of KentuckyOne Health was recently voted the #1 Family Physician as part of the “Best of Kentuckiana” by WHAS TV. Paily has been practicing in Louisville for more than 10 years.
Jewish Hospital & St. Mary’s Foundation Board to invest $18 million in Louisville facilities
LOUISVILLE The Jewish Hospital & St. Mary’s Foundation board of directors has approved the disbursement of more than $18 million from unrestricted funds for facility advancements, advanced clinical research and more. The grants being made by the Foundation represent the largest grants in its history and will enable KentuckyOne Health to better serve the healthcare needs of our community.
The funding disbursements range from a $500,000 investment in making the Kosair Charities Children’s Peace Center at Our Lady of Peace kid-friendly to a $1.5 million grant to continue the hand transplant program, a partnership of physicians and researchers at Jewish Hospital, Kleinert Kutz & Associates, Christine M. Kleinert Institute and the University of Louisville.
The largest single project is a $5 million investment to create a hybrid operating room and Resuscitation Center at Jewish Hospital. The Resuscitation Center, the first in Kentucky, will allow for new, cutting-edge treatments such as the use of hypothermia therapy for some patients in cardiac arrest, a treatment endorsed but The American Heart Association. The hybrid operating room will create more space for innovative new procedures such as transcatheter aortic valve replacement (TAVR) for patients who are not candidates for open-heart surgery but need heart valve replacement.
Other projects funded include:
Purchase of a NOGA® XP Cardiac Navigation System to provide leading-edge evaluation, mapping, and navigation tools to support physicians performing cardiac procedures at Jewish Hospital
Build out of existing space at Frazier Rehab Institute creating a shared space for established clinical research programs conducted in partnership with the University of Louisville to foster interdisciplinary translational research
Two additional locomotor treadmills at Frazier Rehab Institute to expand the nationally recognized spinal cord injury research program with the University of Louisville
Upgrades to existing technology and equipment in intensive care and critical care units at Sts. Mary & Elizabeth Hospital and Jewish Hospital Shelbyville
Additional equipment in the Community Fitness & Wellness Center at Frazier Rehab Institute to serve the wellness needs of disabled individuals in the community
KentuckyOne Health Announces Headquarters Location in Louisville
LOUISVILLE After months of reviewing locations in Kentucky and southern Indiana, including Lexington and Louisville, KentuckyOne Health officials announced that Louisville has been selected as the headquarters location for KentuckyOne Health. The corporate offices will be located in downtown Louisville at 100 East Liberty Street in the Jewish Hospital Medical Plaza building.
Jewish Hospital & St. Mary’s HealthCare in Louisville and Saint Joseph Health System in Lexington merged on January 1, 2012 to form KentuckyOne Health, and recently partnered with University of Louisville Hospital | James Graham Brown Cancer Center. KentuckyOne is the largest health system in Kentucky with more than 200 locations and more than 3,100 licensed beds across the Commonwealth.
Ruth W. Brinkley, president and CEO of KentuckyOne, said, “Downtown Louisville is the right choice for our headquarters for a number of reasons, including the proximity to several of our Louisville facilities; easy access to other areas in the Commonwealth; convenient access to the Louisville International Airport and a location in the largest city in the Commonwealth. In addition, the Jewish Hospital Medical Plaza is already one of our owned assets, which made it a financially viable option.”
“The alignment of our recently announced partnership with the University of Louisville Hospital | James Graham Brown Cancer Center is another reason why this is the right decision,” added Brinkley.
Executives are currently located in the Jewish Hospital Rudd Heart & Lung Center on Abraham Flexner Way in Louisville. The new location is just two blocks away. Plans for the headquarters include two floors with several offices, cubicles, and a number of conference rooms.
While the corporate headquarters will be in Louisville, KentuckyOne Health is a statewide organization. Additional corporate leadership and support offices will remain located throughout the Commonwealth, including Lexington. KentuckyOne Health’s leadership team will continue to travel across the Commonwealth to interact with all constituents.
SEND YOUR NEWS ITEMS TO M.D UPDATE > firstname.lastname@example.org